Navigation Links
Adalimumab may reduce health-care costs for Crohn's disease patients
Date:11/12/2008

Inflammatory bowel disease (IBD) is a term that refers to both ulcerative colitis (UC) and Crohn's disease (CD). IBD occurs most frequently in people in their late teens and twenties. There have been cases in children as young as two years old and in older adults in their seventies and eighties; men and women have an equal chance of getting the disease.

While the cause(s) of IBD are not known, one theory is based on genetics, indicating that IBD runs in families. About 15 percent to 30 percent of patients with IBD have a relative with the disease. Research is underway to find out if a specific gene or a group of genes makes a person more susceptible to getting the disease. Additionally, many changes in the body's immune system have been discovered in patients with IBD. There is a large amount of research being done in this area as well, including studies to find out if IBD is caused by an infectious agent.

Two recent studies published in Gastroenterology and Clinical Gastroenterology and Hepatology further our understanding of these major illnesses.

Adalimumab Therapy May Provide Important Economic Benefits for Crohn's Disease Patients

Crohn's disease (CD) patients treated with adalimumab have lower one-year risks of hospitalization and surgery, reports a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

Adalimumab is an anti-tumor necrosis factor (TNF) monoclonal antibody, of human origin, effective for inducing and maintaining clinical response and remission in patients with moderate to severe CD. It is approved for the treatment of CD in North America and Europe.

All data used in these analyses were collected during the Crohn's Trial of the Fully Human Antibody Adalimumab for Remission Maintenance (CHARM) trial, a multi-center, Phase III, double-blind, randomized, placebo-controlled study. This analysis was the firs
'/>"/>

Contact: Alissa Cruz
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
2. HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
3. Data Show that Abbotts HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
4. Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies
5. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
6. Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
7. Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
8. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
9. Dual treatment for stroke leads to improved recovery rates, reduced mortality
10. Calcium plus vitamin D supplementation is not associated with a reduced breast cancer risk
11. Study: Smoking Ban Would Help Reduce Heart Attack Admissions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 30, 2014 Top10BestSEOHosting.com is a ... have announced that HostGator.com http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts is ... market. Also, they has announced that Bluehost and ... , Hostgator, one of the Top 10 Web ... cheap Windows hosting, and it offers rich features ...
(Date:8/30/2014)... 2014 Ms. Meriwether’s striking beauty is not ... has an impressive resume to boost. Nana is best ... However, she’s also a two time All American UCLA ... trained for the 2008 Olympics and played professional volleyball as ... six-foot beauty from Potomac, Maryland is a two-time, All American ...
(Date:8/30/2014)... August 30, 2014 Final Cut ... of the TransGhost plugin from Pixel Film Studios. , ... users the ability to tell their scary story in ... Film Studios. “Users will make their audience scream with ... , With TransGhost users can awaken evil spirits with ...
(Date:8/30/2014)... Boston, MA (PRWEB) August 30, 2014 ... nurse practitioner locum tenens company , announces a ... September 1, 2014. Barton Associates is headquartered in Peabody, ... CT; Keene, NH; Austin, TX; and Jupiter, FL. , ... in response to the physician shortage crisis affecting the ...
(Date:8/30/2014)... Spain Saturday 30 August 2014: The first ... The novel document compiles current evidence on the ... agreed by international experts from three continents. , ... published today on-line in EP Europace ... Heart Rhythm Association (EHRA) of the European Society ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: HostGator.com Is The Best Windows Hosting Supplier 2Health News:NJ Top Dentists Announces Cover Model for the Healthy Living: Top Dentists Issue 2Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 2Health News:Pixel Film Studios Released TransGhost Plugin for Final Cut Pro X Today 3Health News:Barton Associates to Open a New Office Location in Keene, NH 2Health News:First expert consensus on ventricular arrhythmias published 2Health News:First expert consensus on ventricular arrhythmias published 3
... baby of a single parent has been born in a ... the single father's parenthood rights. // , ,Amit Banerjee, ... apparently the country's first single father whose son was born ... People think that couples go to these clinics only when ...
... Type 2 diabetes, characterized by insulin resistance and/or ... to expand unabated throughout the world. The development ... decreased physical activity, decreased functional capacity, increased body ... age and heredity., ,Both diabetes and smoking ...
... Bitten by patent rows over basmati and turmeric, India doesn't ... certainly not when it comes to its ancient healing systems ... force appointed by the government for protecting traditional knowledge and ... and techniques as well as formulae in ayurveda, siddha and ...
... is a life-threatening condition that frequently requires hospitalization ... factors in the treatment of DKA include careful ... and electrolyte adjustment, and the initiation of insulin ... has been achieved. Continuous low-dosage intravenous infusion of ...
... a well-known fact. This habit does not spare your ... chronic smoking injures the teeth, causing the distinctive brownish ... frequency of tooth loss in chronic smokers' has been ... are more prone to develop chronic periodontitis, the disease ...
... elderly woman suffering from multiple nodules and cysts in ... without any trauma on the neck//. ,A ... two-hour-long operation - Bloodless Endoscopic Thyroidectomy - through the ... last week. ,"Endoscopic approaches are being used worldwide ...
Cached Medicine News:Health News:A first for India - IVF baby born of surrogacy 2Health News:Cigarette Smoking Leads To Development Of Type 2 Diabetes In Patients With Coronary Artery Disease 2Health News:Yoga, ayurveda being documented to stop patent misuse 2Health News:Endoscopic Thyroidectomy Helps In Removing Thyroid Cysts 2
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
(Date:8/29/2014)... /PRNewswire-iReach/ -- ChemImage will present a workshop focused on ... Forensic Science Society,s 22 nd International Symposium ... Australia .  Forensic Scientists will be in ... imaging can bring to examination procedures. ... Product Development at ChemImage, will host a workshop ...
(Date:8/29/2014)... Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... instrumentation and consumables to the medical, research and veterinary ... and Chief Executive Officer, will present at the CL ... on Tuesday, September 9, 2014 at 12:30 p.m. ET. ... Place Hotel in New York City ...
Breaking Medicine Technology:Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... , , , , ... Obama,s push for health care reform, the Senate rejected a ... federally approved drugs from abroad. That vote has proved to ... Canadameds.com ( http://www.Canadameds.com ), which sells low-cost prescription drugs directly ...
... , , Accelerated approval process used in vaccine ... U.S. Food and Drug Administration today approved Fluzone High-Dose, an ... older to prevent disease caused by influenza virus subtypes A ... , People in this age group are at highest risk ...
Cached Medicine Technology:Senate Rejects Bulk Imports of Medicine from Canada, but Personal Importation Remains a Popular Option for U.S. Citizens 2Senate Rejects Bulk Imports of Medicine from Canada, but Personal Importation Remains a Popular Option for U.S. Citizens 3FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older 2FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older 3
... contains primers and a FAM-labeled probe that ... gene. In addition, this ASR contains primers, ... internal control sequence. This ASR requires an ... Red reporter dyes such as the Cepheid ...
...
Reptilase-Time from Bothrops atrox...
Thrombin Activatable Fibrinolysis Inhibitor Assay Kit...
Medicine Products: